CODARD (Respa Pharmaceuticals)


Welcome to the PulseAid listing for the CODAR drug offered from Respa Pharmaceuticals. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Respa Pharmaceuticals
NON-PROPRIETARY NAME: Codeine Phosphate, Pseudoephedrine Hydrochloride
SUBSTANCE NAME: CODEINE PHOSPHATE; PSEUDOEPHEDRINE HYDROCHLORIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2011-07-13
END MARKETING DATE: 0000-00-00


CODAR D HUMAN OTC DRUG Details:

Item DescriptionCODAR D from Respa Pharmaceuticals
LABELER NAME: Respa Pharmaceuticals
DEA SCHEDULE: CV
ACTIVE STRENGTH: 8; 30(mg/5mL; mg/5mL)
START MARKETING DATE: 2011-07-13
END MARKETING DATE: 0000-00-00
PRODUCT ID: 60575-515_076f7810-5c2b-4d9b-9a69-4308cb9440ca
PRODUCT NDC: 60575-515
APPLICATION NUMBER: part341

Other CODEINE PHOSPHATE; PSEUDOEPHEDRINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Respa PharmaceuticalsCODAR